Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor Malignancies × vadimezan × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Neoplasm Metastasis 4 Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Unspecified Adult Solid Tumor, Protocol Specific 1 Solid Tumors 1 Solid Tumor Malignancies 1 Prostatic Neoplasms 1 Lung Neoplasms 1 Carcinoma, Transitional Cell 1 Advanced or Recurrent Solid Tumors 1

Interventions

pembrolizumab 3 vadimezan 1 malic acid 1 Valproic Acid 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01290380 2011-09-02

A Study to Evaluate the Effects of ASA404 Alone or in Combination With Taxane-based Chemotherapies on the Pharmacokinetics of Drugs in Patients With Advanced Solid Tumor Malignancies

Novartis

Phase 1 Terminated

Other solid neoplasm

Solid Tumor Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡